drug

Hyoscine

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Mersey Care NHS Trust
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Clozapine-induced Hypersalivation - Feasibility Trial
NCT02613494Phase 1, Phase 2Completed

KOLs & investigators

1
Dr.Inti Qurashi, MDKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Mersey Care NHS Trust
company
trial
Clozapine-induced Hypersalivation - Feasibility Trial
PHASE1, PHASE2
trial
indication
Sialorrhea
indication
Schizophrenia, Treatment-Resistant
indication
Sialorrhea
indication
KOL
Dr.Inti Qurashi, MD
KOL score 5
person